Axcelis Technologies, Inc. (ACLS)
NASDAQ: ACLS · Real-Time Price · USD
63.11
-1.38 (-2.14%)
At close: Feb 21, 2025, 4:00 PM
62.22
-0.89 (-1.41%)
After-hours: Feb 21, 2025, 5:11 PM EST
Company Description
Axcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Japan, Europe, and Asia Pacific.
The company offers high energy, high current, and medium current implanters for various application requirements.
It also provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training.
It sells its equipment and services to semiconductor chip manufacturers through its direct sales force.
The company was founded in 1978 and is headquartered in Beverly, Massachusetts.
Axcelis Technologies, Inc.
Country | United States |
Founded | 1995 |
IPO Date | Jul 11, 2000 |
Industry | Semiconductor Equipment & Materials |
Sector | Technology |
Employees | 1,620 |
CEO | Russell Low |
Contact Details
Address: 108 Cherry Hill Drive Beverly, Massachusetts 01915-1088 United States | |
Phone | 978 787 4000 |
Website | axcelis.com |
Stock Details
Ticker Symbol | ACLS |
Exchange | NASDAQ |
Stock Type | Common Stock |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001113232 |
CUSIP Number | 054540208 |
ISIN Number | US0545402085 |
Employer ID | 34-1818596 |
SIC Code | 3559 |
Key Executives
Name | Position |
---|---|
Dr. Russell J. Low Ph.D. | Chief Executive Officer, President and Director |
James G. Coogan | Executive Vice President and Chief Financial Officer |
Gregory F. Redinbo Ph.D. | Executive Vice President of Marketing and Applications |
Lynnette C. Fallon Esq., J.D. | Executive Vice President of Human Resources and Legal |
Gerald M. Blumenstock | Executive Vice President of Research, Development and Engineering |
Robert Mahoney | Senior Vice President of Global Operations |
David Ryzhik | Senior Vice President of Investor Relations and Corporate Strategy |
Eileen J. Evans Esq. | Executive Vice President and General Counsel |
Dr. Christopher Tatnall Ph.D. | Executive Vice President of Global Customer Operations |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Feb 10, 2025 | 8-K | Current Report |
Jan 30, 2025 | SCHEDULE 13G/A | Filing |
Jan 10, 2025 | 8-K | Current Report |
Nov 8, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Nov 7, 2024 | 10-Q | Quarterly Report |
Nov 6, 2024 | 8-K | Current Report |
Oct 18, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Aug 29, 2024 | 144 | Filing |
Aug 6, 2024 | 144 | Filing |
Aug 1, 2024 | 10-Q | Quarterly Report |